clarithromycin has been researched along with Colorectal Cancer in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Arcangeli, A; Bagni, G; Becchetti, A; Duranti, C; Iorio, J; Kragol, G; Lottini, T; Petroni, G; Stefanini, M | 1 |
Doki, Y; Eguchi, H; Hayashi, N; Kagawa, Y; Komori, T; Matsuda, C; Mizushima, T; Morita, S; Murata, K; Nakata, K; Noura, S; Ota, H; Saso, K; Satoh, T; Uemura, M | 1 |
Makihara, K; Miyagi, K; Nakamura, S; Nakata, I; Ueno, H | 1 |
Donadoni, G; Ferreri, AJ; Govi, S; Kiesewetter, B; Raderer, M; Sassone, M; Scarfò, L | 1 |
Akazawa, Y; Ichikawa, T; Isomoto, H; Matsushima, K; Nakao, K; Ohnita, K; Senoo, T; Shiozawa, K; Takeshima, F; Yamaguchi, N | 1 |
2 trial(s) available for clarithromycin and Colorectal Cancer
Article | Year |
---|---|
Pre-emptive oral clarithromycin reduces the skin toxicity of panitumumab treatment for metastatic colorectal cancer.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Clarithromycin; Colorectal Neoplasms; Humans; Panitumumab | 2021 |
High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): the HD-K phase II trial.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Breast Neoplasms; Clarithromycin; Colorectal Neoplasms; Disease-Free Survival; Eye Neoplasms; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Mouth Neoplasms; Neoplasms, Multiple Primary; Salvage Therapy; Skin Neoplasms; Stomach Neoplasms | 2015 |
3 other study(ies) available for clarithromycin and Colorectal Cancer
Article | Year |
---|---|
Clarithromycin inhibits autophagy in colorectal cancer by regulating the hERG1 potassium channel interaction with PI3K.
Topics: Antineoplastic Agents; Apoptosis; Autophagosomes; Autophagy; Cell Line, Tumor; Cell Survival; Clarithromycin; Colonic Neoplasms; Colorectal Neoplasms; Ether-A-Go-Go Potassium Channels; Humans; Phosphatidylinositol 3-Kinases; Signal Transduction | 2020 |
Clarithromycin co-administration does not increase irinotecan (CPT-11) toxicity in colorectal cancer patients.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Clarithromycin; Colorectal Neoplasms; Female; Humans; Irinotecan; Male; Middle Aged; Retrospective Studies | 2017 |
Successful management of cap polyposis with eradication of Helicobacter pylori relapsing 15 years after remission on steroid therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Colorectal Neoplasms; Endoscopy, Digestive System; Female; Glucocorticoids; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Polyposis; Prednisolone; Rabeprazole; Recurrence; Remission Induction | 2012 |